Laboratory of Molecular Immunology, The Rockefeller University, New York, NY 10065, USA.
Technion - Israel Institute of Technology, Haifa 320003, Israel.
Cell Rep. 2022 Sep 6;40(10):111311. doi: 10.1016/j.celrep.2022.111311.
Antiretroviral therapy controls, but does not cure, HIV-1 infection due to a reservoir of rare CD4 T cells harboring latent proviruses. Little is known about the transcriptional program of latent cells. Here, we report a strategy to enrich clones of latent cells carrying intact, replication-competent HIV-1 proviruses from blood based on their expression of unique T cell receptors. Latent cell enrichment enabled single-cell transcriptomic analysis of 1,050 CD4 T cells belonging to expanded clones harboring intact HIV-1 proviruses from 6 different individuals. The analysis reveals that most of these cells are T effector memory cells that are enriched for expression of HLA-DR, HLA-DP, CD74, CCL5, granzymes A and K, cystatin F, LYAR, and DUSP2. We conclude that expanded clones of latent cells carrying intact HIV-1 proviruses persist preferentially in a distinct CD4 T cell population, opening possibilities for eradication.
抗逆转录病毒疗法可以控制,但不能治愈 HIV-1 感染,因为存在携带潜伏前病毒的罕见 CD4 T 细胞库。人们对潜伏细胞的转录程序知之甚少。在这里,我们报告了一种从血液中富集携带完整、复制能力的 HIV-1 前病毒的潜伏细胞克隆的策略,该策略基于它们表达独特的 T 细胞受体。潜伏细胞的富集使我们能够对来自 6 名个体的携带完整 HIV-1 前病毒的扩增克隆中的 1050 个 CD4 T 细胞进行单细胞转录组分析。分析表明,这些细胞大多数是 T 效应记忆细胞,这些细胞表达 HLA-DR、HLA-DP、CD74、CCL5、颗粒酶 A 和 K、半胱氨酸蛋白酶抑制剂 F、LYAR 和 DUSP2。我们的结论是,携带完整 HIV-1 前病毒的潜伏细胞扩增克隆优先存在于一个独特的 CD4 T 细胞群体中,这为根除提供了可能性。